Alkermes plc
Sector
Location
Market Cap
USD 4.38 B
Share Price
USD 26.54
Avg Daily Volume
1,783,541
Change (1 day)
Change (1 year)
Change (YTD)
Eli Lilly and Company
USD 635.22
LLY
Neurocrine Biosciences, Inc.
USD 123.98
NBIX
Corcept Therapeutics Incorporated
USD 71.97
CORT
Jazz Pharmaceuticals plc
USD 110.75
JAZZ
SK Biopharmaceuticals Co., Ltd.
USD 71.61
326030.KS
Axsome Therapeutics, Inc.
USD 103.96
AXSM
H. Lundbeck A/S
USD 5.42
HLUN-B.CO
ACADIA Pharmaceuticals Inc.
USD 24.82
ACAD
Indivior PLC
USD 22.29
INDV
Supernus Pharmaceuticals, Inc.
USD 40.57
SUPN
Biohaven Ltd.
USD 13.41
BHVN
AbbVie Inc.
USD 198.64
ABBV
Roche Holding AG
USD 317.50
RO.SW
AstraZeneca PLC
USD 150.15
AZN.L
Novartis AG
USD 117.98
NOVN.SW
Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
---|
Eli Lilly and Company
USD 635.22
LLY
Neurocrine Biosciences, Inc.
USD 123.98
NBIX
Corcept Therapeutics Incorporated
USD 71.97
CORT
Jazz Pharmaceuticals plc
USD 110.75
JAZZ
SK Biopharmaceuticals Co., Ltd.
USD 71.61
326030.KS
Axsome Therapeutics, Inc.
USD 103.96
AXSM
H. Lundbeck A/S
USD 5.42
HLUN-B.CO
ACADIA Pharmaceuticals Inc.
USD 24.82
ACAD
Indivior PLC
USD 22.29
INDV
Supernus Pharmaceuticals, Inc.
USD 40.57
SUPN
Biohaven Ltd.
USD 13.41
BHVN
AbbVie Inc.
USD 198.64
ABBV
Roche Holding AG
USD 317.50
RO.SW
AstraZeneca PLC
USD 150.15
AZN.L
Novartis AG
USD 117.98
NOVN.SW